.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Mallinckrodt
Federal Trade Commission
Merck
QuintilesIMS
Johnson and Johnson
Accenture
Farmers Insurance
Cantor Fitzgerald
Fuji

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017853

« Back to Dashboard
NDA 017853 describes PROVENTIL, which is a drug marketed by Schering and 3m Drug Delivery and is included in six NDAs. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the PROVENTIL profile page.

The generic ingredient in PROVENTIL is albuterol. There are thirty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the albuterol profile page.

Summary for 017853

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 017853

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 7, 1982TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 7, 1982TE:RLD:Yes

Expired Orange Book Patents for NDA: 017853

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering
PROVENTIL
albuterol sulfate
TABLET;ORAL017853-001May 7, 1982► Subscribe► Subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET;ORAL017853-002May 7, 1982► Subscribe► Subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET;ORAL017853-002May 7, 1982► Subscribe► Subscribe
Schering
PROVENTIL
albuterol sulfate
TABLET;ORAL017853-001May 7, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Julphar
Chinese Patent Office
UBS
Citi
US Army
Accenture
Medtronic
Novartis
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot